ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

RAC Grumbles, Gives Healy Guidelines For Compassionate Use Of Gene Therapy

January 22, 1993

In Brief: Hood to form Institute for Systems Biology, To Unite Biologists, High-Tech Industry

December 17, 1999

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

June 17, 1977

Organ Systems R01 Grants Doing Okay

February 8, 1985

New Methods Uncover 1,800 RNAs Linked To Breast Cancer

December 30, 2011

HCFA Sees Applications For DRGs And Research

September 27, 1985